THE Therapeutic Goods Administration has issued an alert about "false and misleading claims" being made by some companies supplying cannabidiol (CBD) products in Australia.
In an update issued yesterday the TGA said companies located in the US have been illegally exporting CBD and hemp products to recipients in Australia without import permission.
"The TGA is aware of at least one company who has claimed that the TGA has invited them to register their CBD and hemp products on the Australian Register of Therapeutic Goods (ARTG) due to growing demand," the agency said.
"This is incorrect...the TGA does not 'invite' businesses or sponsors to register a product on the ARTG.
"The onus is on the sponsor to apply to the TGA and follow due process," the update continued.
In this case the company has also claimed it will have its products registered and approved by the TGA 'very quickly,' the items in question are not currently registered by the US Food and Drug Administration "and they are therefore unlikely to receive registration by the TGA".
The items are also subject to regulation and export control by the US Drug Enforcement Agency.
The TGA warned that illegal imports would be seized at the border, and noted that any importers of CBD/hemp oils are also breaking the law on supply and use of prescription medicines.
More details at www.tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 May 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 May 18